Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: from letter to shareholders

from letter to shareholders

posted on Feb 08, 2008 04:26PM

"and we hope that our activities in the near future will lead to increased investor confidence that will be reflected in a higher share price."

Is Pohl's resignation the first of "our activities in the near future"?

Our activities, obviously refers to efforts by Patriot management and BOD, and not to licensing by TPL/Alliacense. What else can we expect on the heels of this announcement? Hopefully, it was part of a plan and it is now proceeding.

1
Feb 08, 2008 05:01PM
Share
New Message
Please login to post a reply